Credence MedSystems Announces Strategic Collaboration With Phillips-Medisize
Retrieved on:
Tuesday, October 19, 2021
Biotechnology, Pharmaceutical, Other Manufacturing, Medical Supplies, Health, Medical Devices, Engineering, Manufacturing, Clinical trial, Administration, Conditional sentence, Dual, Investment, No innovation without representation, Technology, Â, Health, Life, Multimedia, Syringe, FDA, Industry, Electronics, Compliance, Measuring instrument, Solution, Novartis, Safety, Pharmaceutical industry, Online shopping, Credence MedSystems, Inc., Phillips-Medisize, Molex, CREDENCE MEDSYSTEMS, INC., PHILLIPS-MEDISIZE, MOLEX
Credence MedSystems, Inc. announced today that it has formed a strategic collaboration with Phillips-Medisize, a Molex company, a global leader in the design and manufacturing of solutions for the pharmaceutical drug delivery market.
Key Points:
- Credence MedSystems, Inc. announced today that it has formed a strategic collaboration with Phillips-Medisize, a Molex company, a global leader in the design and manufacturing of solutions for the pharmaceutical drug delivery market.
- (Graphic: Business Wire)
The strategic relationship will support scaling of the manufacture of the Credence Companion and Dual Chamber Reconstitution Systems. - The Credence Connect Auto-Sensing Injection System is a connected solution for syringes targeting chronic disease management and enabling improved clinical trial compliance.
- Credence MedSystems is an innovator of drug delivery systems that solve unmet market needs for the pharmaceutical industry.